Geriatric Psychiatry and Neurology

Psychiatric disorder, is a mental or behavioral or  condition that causes significant distress or impairment of personal functioning. Such features may be persistent, relapse and remitting, or occur as a single episode. Common psychiatric disorders include depression, which affects about 400 million, dementia which affects about 35 million, and schizophrenia, which affects about 21 million people globally. Stigma and discrimination will augment the suffering and incapacity associated with mental disorders, resulting in various social movements trying to extend understanding and challenge social exclusion.

TOPICS
The Ongoing Challenge of Psychiatric Diagnosis, Advances in Psychiatric Genetics and Genomics, Advances in Psychiatric Imaging, Psychiatric Therapeutics, Mental Health ,Psychiatric Nursing, Geriatric and Paediatric Psychiatry, Psychiatry and Psychological Disorders, Women Mental Health and Illness, Bipolar and Related Disorders, Neurocognitive Disorders

MARKET
The global Psychiatric disorder therapeutics market is divided into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World. North America dominates the market with the U.S. accounting for a major market share. Nearly one in 5 (18.5%) Americans experiences mental state issues every year. In the U.S., an estimated 9.8 million, which equated to nearly 4.8% of all adults (over 18 years of age) had serious mental disorders. Europe is taken into account as the second largest region in the psychotherapies market. Presence of multiple psychotherapy associations such as the UK Council for Psychotherapy, the British Psychoanalytic Council, and the British Association for Counselling and Psychotherapy drives the market growth. The market in Asia is predicted to expand at the highest CAGR during the forecast period. This growth can be attributed to government initiatives, increased demand for mental health services, and rising focus of major players on the markets such as India. Emerging markets such as China, India and countries in the Middle East region offer great opportunities for this market as a result of changing lifestyle coupled with increasing psychological disease awareness among people.  Expenses for mental health services were expected to grow to around 203.6 billion dollars by 2017. In 2009, mental health expenditures accounted for 6.3 percent of all health expenditures within the U.S., However were expected to account for only 5.6 percent by 2017.


               
SESSIONS
The Ongoing Challenge of Psychiatric Diagnosis, Advances in Psychiatric Genetics and Genomics, Advances in Psychiatric Imaging, Psychiatric Therapeutics, Mental Health ,Psychiatric Nursing, Geriatric and Paediatric Psychiatry, Psychiatry and Psychological Disorders, Women Mental Health and Illness, Bipolar and Related Disorders, Neurocognitive Disorders

Target Audience :

Neuroscientists, Neurologists, Directors, Physicians, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students

Tags :

neurology,neurology2021,neurologyconference,neurologycongress,neuroscience,neuroscienceconference,neuroscience2021,neurosciencecongress,dementiaconference,neurologymeetings,neurologysummit,neuroscienceconferences,dementiacongress,neurologyeurope,neurologistconference,neuroscientist,dementia,alzheimersdisease

Get In Touch

Venue

Hotel NH Valencia Center, Valencia, Spain

Call Us

+1 4693420402
Abstract Deadline
30/04/2020